Real-life experience of upadacitinib for the treatment of adult patients with moderate-to-severe atopic dermatitis - a case series.
J Eur Acad Dermatol Venereol
; 36(10): e832-e833, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35680538
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
Limits:
Adult
/
Humans
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2022
Document type:
Article
Affiliation country:
Israel
Country of publication:
United kingdom